Report on the international colloquium on cardio-oncology (rome, 12-14 march 2014).

摘要: Cardio-oncology is a relatively new discipline that focuses on the cardiovascular sequelae of anti-tumour drugs. As any other young adolescent discipline, cardio-oncology struggles to define its scientific boundaries and identify best standards care for cancer patients or survivors at risk events. The International Colloquium Cardio-Oncology was held in Rome, Italy, 12-14 March 2014, with aim illuminating controversial issues unmet needs modern cardio-oncology. This colloquium embraced contributions from different kind disciplines (oncology cardiology but also paediatrics, geriatrics, genetics, translational research); fact, goes way beyond merging oncology. Moreover, programme did not review toxicity one drug other, rather it looked as we see them their fight against eventually returning everyday life. represents melting pot which anti-cancer therapies, genetic backgrounds, factors conspire producing sequelae, this calls screening programmes well-designed platforms collaboration between key professional figure another. promoted by Menarini Foundation co-chaired Giorgio Minotti (Rome), Joseph R Carver (Philadelphia, Pennsylvania, United States), Steven E Lipshultz (Detroit, Michigan, States). split into five sessions broad investigational clinical relevance (what cardiotoxicity?, cardiotoxicity children, adolescents, adults, special populations, future cardio-oncology). Here, chairs all session briefly summarised what said colloquium. Topics controversies were reported behalf members working group Cardio-Oncology.